[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341546-105":59,"doc-detail-341546-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploring-the-prognostic-implications-of-cuproptosis-associated-alterations-in-clear-cell-renal-cell-carcinoma-via-in-vitro-experiments","Exploring the prognostic implications of cuproptosis-associated alterations in clear cell renal cell carcinoma via in vitro experiments","","Investigation of how novel copper ionophores influence prognosis and the tumor microenvironment in clear cell renal cell carcinoma (ccRCC). Expression profiles of 10 cuproptosis genes and 40 TME-pathway genes were quantified across 531 tumor and 71 adjacent samples from The Cancer Genome Atlas, and a LASSO Cox risk-score model was built to predict patient outcomes. High-risk scores aligned with stronger anti-tumor immune activity yet included more T follicular helper and regulatory T cells. RNAi depletion of FDX1 and PDHB reduced ccRCC proliferation and migration in 786-O and ACHN cells, supporting cuproptosis-based therapeutic potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-the-prognostic-implications-of-cuproptosis-associated-alterations-in-clear-cell-renal-cell-carcinoma-via-in-vitro-experiments/341546/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-the-prognostic-implications-of-cuproptosis-associated-alterations-in-clear-cell-renal-cell-carcinoma-via-in-vitro-experiments/341546.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data and model were used to assess prognostic implications in ccRCC?","Question",{"text":112,"@type":113},"The study measured differential expression of 10 cuproptosis-related and 40 TME-pathway-related genes in TCGA samples, then built a LASSO Cox risk-score model to predict ccRCC prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did high and low risk-score groups differ in the tumor immune microenvironment?",{"text":117,"@type":113},"Higher risk scores were associated with increased immune responses, with more anti-tumor lymphocytes and fewer immunosuppressive M2-like macrophages, but also higher proportions of T follicular helper cells and regulatory T cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What in vitro experiments tested cuproptosis gene functions in ccRCC cells?",{"text":121,"@type":113},"RNAi stable depletion models of FDX1 and PDHB were created in 786-O and ACHN cells, and CCK8, colony formation, and Transwell assays showed reduced proliferation and migration after knockdown.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341546,1790700669,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nExploring the prognostic implications of cuproptosis‑associated alterations in clear cell renal cell carcinoma via in vitro experiments  \nZhaoyu Xing1, Li Cui1, Yuehua Feng2, Yang Yang3 & Xiaozhou He 1*  \nThis study investigated the impact of novel copper ionophores on the prognosis of clear cell renal cell carcinoma (ccRCC) and the tumor microenvironment (TME). The differential expression of 10 cuproptosis and 40 TME‑pathway‑related genes were measured in 531 tumor samples and 71 adjacent kidney samples in The Cancer Genome Atlas database. A risk score model was constructed with LASSO cox to predict the prognosis of ccRCC patients. Forest plot and function enrichment were used to study the biological function of the key genes in depth. The study found that the risk score model accurately predicted the prognosis of ccRCC patients. Patients with high scores had higher immune responses with a higher proportion of anti‑tumor lymphocytes and a lower proportion of immunosuppressive M2‑like macrophages. However, the high‑score group also exhibited a higher proportion ofT follicular helper cells and regulatory T cells. These results suggest that cuproptosis‑based therapy may be worth further investigation for the treatment of ccRCC andTME. Subsequently, by using RNAi, we established the stable depletion models of FDX1 and PDHB in ccRCC cell lines 786‑O and ACHN. Through CCK8, colony formation, and Transwell assays, we observed that the knockdown of FDX1 and PDHB could significantly reduce the capabilities of proliferation and migration in ccRCC cells. In conclusion, this study illuminates the potential effectiveness of copper ionophores in the treatment of ccRCC, with higher risk scores correlating with better TME immune responses. It sets the stage for future cuproptosis‑based therapy research in ccRCC and other cancers, focusing on copper’s role in  \nTME.  \nKeywords Cuproptosis, TME, ccRCC, Immune response, Immunosuppressive  \nRenal cell carcinoma (RCC) is a common worldwide malignant tumor that ranks 10th place in its occurrence among men and women and is estimated to have 79,000 new cases and caused 13,920 deaths in 20221. Originating from renal tubular epithelial cells, clear cell renal cell carcinoma (ccRCC) comprises 70–80% of all the subtypes of RCC. Although ccRCC patients have benefitted significantly from the advancement of surgical instruments and strategies, late-stage ccRCC patients, especially metastasis ccRCC patients, still face a high mortality rate2,3. The emergence of immune checkpoint inhibitors (ICIs) represents a therapeutic revolution in the last decade. Several clinical trials have reported that immunotherapy has become an effective therapeutic strategy for a variety of solid tumors, including RCC4–6. The mechanism of action of ICI is based on the activation of the immune system, which can modulate T lymphocytes and target immune checkpoints such as programmed cell death protein 1 (PD-1) and programmed cell death ligand 1 (PD-L1)7. Previous studies have demonstrated the safety and efficacy of immunotherapies such as ipilimumab plus nivolumab combination in the treatment of metastatic RCC8,9. In this regard, a deeper understanding of the immune characteristics of RCC is of great significance to improve the efficacy of immunotherapy.  \n1The Department of Urology, The Third Affiliated Hospital, Soochow University, Changzhou, Jiangsu Province, China. 2The Department of Comprehensive Laboratory, The Third Affiliated Hospital, Soochow University, Changzhou, Jiangsu Province, China. 3The Department of Hepatobiliary Surgery, The Third Affiliated Hospital,  \nSoochow University, Changzhou, Jiangsu Province, China.* email: [hxz911@sina.com](hxz911@sina.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nCopper has been documented as an essential trace element in almost every organism, from bacteria to human cell","cbCaieshboVucGbK","https://ap.wps.com/l/cbCaieshboVucGbK","pdf",3482263,"English","# Introduction\n## Background of ccRCC and immune checkpoint therapy\n## Role of copper and cuproptosis in cancer\n# Study aim\n## Cuproptosis and TME pathway alterations and clinical outcomes","[{\"question\":\"What data and model were used to assess prognostic implications in ccRCC?\",\"answer\":\"The study measured differential expression of 10 cuproptosis-related and 40 TME-pathway-related genes in TCGA samples, then built a LASSO Cox risk-score model to predict ccRCC prognosis.\"},{\"question\":\"How did high and low risk-score groups differ in the tumor immune microenvironment?\",\"answer\":\"Higher risk scores were associated with increased immune responses, with more anti-tumor lymphocytes and fewer immunosuppressive M2-like macrophages, but also higher proportions of T follicular helper cells and regulatory T cells.\"},{\"question\":\"What in vitro experiments tested cuproptosis gene functions in ccRCC cells?\",\"answer\":\"RNAi stable depletion models of FDX1 and PDHB were created in 786-O and ACHN cells, and CCK8, colony formation, and Transwell assays showed reduced proliferation and migration after knockdown.\"}]","Exploring the prognostic implications of cuproptosis-associated alterations in clear cell renal cell carcinoma via in vitro experiments | PDF",1790042479,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c989605cb7230ea6cfee1ce3bdbc6ce6.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a298da24bf89a9be1b73c0a3328de9a2.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57ffa36604b1ebb3c278b554fd6cbab4.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b27f22d47532925c65751561f4bae932.webp",980,1287]